IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Keep in touch with IntegrChain through our news and frequent events.
View all news & events
July 27, 2020 | Mia Scioscia
The latest ICyte Platform Summer Release is all about data actionability. We’ve now made it easier than ever to provide better, deeper visibility into your data within our single access platform so you can proactively simplify your everyday tasks and spend less time dealing with data quality.
Here are the 5 enhancements we’re most excited about:
Data Aggregation & Stewardship
Analytics
Interested in finding out more? Get a closer look at some of these data enhancements below:
Patient Data Aggregation
Our new Patient Data Aggregation updates are all about timeliness and quality of your data. The longer a patient has waiting to get therapy, the greater the chance that the patient will never start therapy. You need to be able to take action quickly on data you can trust and it all starts with patient data aggregation. These are the tools that ensure your data is on time, when you expect it, and that it’s of the highest possible quality. And if it’s not, multiple stakeholders at IntegriChain are here to support you on a daily, weekly, and quarterly basis.
Required Fields-Daily Dashboard
This view allows you to be able to understand which individual fields in the data the pharmacy has been struggling to report. Until now, manufacturers have never had the level of insight to easily identify data quality issues. This ICyte view identifies specific problematic data files so it can be communicated to specialty pharmacies in a consistent manner. This way, specialty pharmacies can clearly see the issues effectively and take appropriate action to resolve them. Being able to configure your data quality contract level down to a field level covered by brand is something that’s entirely unique to IntegriChain.
Quality Control Multiple Longitudinal IDs
The screen shot above shows how ICyte validates the data quality of missing data. When you’re trying to have a conversation about a patient case, it’s really hard to trust the data if there are so many different identifiers for a single patient case. This view enables you and your pharmacy and patient services partners to speak a common language about patient cases, syncing patient IDs regardless of where the source of the data is from. By creating this level of insight for each patient case, ICyte allows you as well as IntegriChain data stewards to identify data quality issues, ensuring that in the future when patient cases are discussed, both the pharmacy and the manufacturer can feel confident that they’re always discussing the same patient.
Refined Patient Data
IntegriChain meets the market need for not only a data partner that will ensure that your files are on time and accurate but the information reported within that data is accurate and insightful.
Patient Status Timeliness
When reviewing open patient statuses view on ICyte, you can find out how many days it has been since you received the last status for that patient. In this instance above, you can easily see that there hasn’t been an update in almost 15 days 40% of patients. This tool allows you to identify and build a report of all of these stalled patient cases. This view and report allow you to constructively discuss corrective action about stalled patient statuses from the pharmacy. This type of insight is something Life Sciences manufacturers have never had the ability to do. Further, we’ve been actively advocating for manufacturers to add this type of timeliness language about status updates in their pharmacy contracts and create a standardization with performance metrics.
Failed Patient Status Rules
This enhancement to the summer release is an update on patient status timeliness. In the screenshot above, you can see patients who did not adhere to therapy by their referral dates and last status dates. This will help create visibility into patients who did not adhere to therapy so problems in the specialty pharmacy can be triaged sooner. Customers have had great success using this insight into sub-status utilization, not only to get the status data information remapped for their utilization, but also to drive operational processes and provide better care to patients.
First reported status
This view above is a differentiated data quality view not just telling you which patients have updates from which pharmacy, but also how long it takes you to get that status update.
Conclusion
These data enhancements will help you streamline your everyday tasks with real-time, granular, and actionable data visibility you can trust, all within a single dashboard. For more information on what else is available in this release, your customer success manager or account director would love to hear from you.
